China Sky One Obtains CE Marks As It Sets Its Sights On International Markets
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - NASDAQ-listed China Sky One Medical has received European Union CE Mark status for its Myocardial Infarction and Urine Microalbumin diagnostic test kits. Meeting the EU health and safety standards of products ensures the company can expand to international markets, and it is now seeking partnerships with leading international distributors
You may also be interested in...
China Sky One Blames U.S. Media Reports For Driving Down NASDAQ Share Price
BEIJING - Just months after threatening to sue an American shareholder for posting negative reports about China Sky One Medical on a U.S. Web site, the leadership of NASDAQ-traded Sky One has issued a new public declaration that unfavorable media reports about the firm that have been driving down its share price are unfounded and reckless
China Sky One Blames U.S. Media Reports For Driving Down NASDAQ Share Price
BEIJING - Just months after threatening to sue an American shareholder for posting negative reports about China Sky One Medical on a U.S. Web site, the leadership of NASDAQ-traded Sky One has issued a new public declaration that unfavorable media reports about the firm that have been driving down its share price are unfounded and reckless
China Sky One Listed On NASDAQ, Recognized By Chinese Government For Innovation With Prestigious Award
SHANGHAI - China Sky One Medical has succeeded in having its shares listed on the NASDAQ Global Select Market in a move that Sky's CEO said demonstrates the company's solid financial performance over the past three years and strong future outlook